Literature DB >> 11100129

Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'.

B Prakken1, M Wauben, D Genini, R Samodal, J Barnett, A Mendivil, L Leoni, S Albani.   

Abstract

Recent progress in molecular medicine has provided important tools to identify antigen-specific T cells. In most cases, the approach is based on oligomeric combinations of recombinant major histocompatibility complex-peptide complexes fixed to various rigid supports available for binding by the T-cell receptor. These tools have greatly increased our insight into mechanisms of immune responses mediated by CD8+ T cells. Examples of the diverse fields of application for this technology include immunization, viral infections and oral tolerance induction.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11100129     DOI： 10.1038/82231

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  24 in total

Review 1.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

2.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

3.  T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.

Authors:  Nina C Flerin; Huabiao Chen; Tynisha D Glover; Pedro A Lamothe; Jian Hua Zheng; Justin W Fang; Zaza M Ndhlovu; Evan W Newell; Mark M Davis; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 4.  Targeted immunomodulation using antigen-conjugated nanoparticles.

Authors:  Derrick P McCarthy; Zoe N Hunter; Bryce Chackerian; Lonnie D Shea; Stephen D Miller
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-03-10

Review 5.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

Review 6.  Biomimetic delivery with micro- and nanoparticles.

Authors:  Stephen C Balmert; Steven R Little
Journal:  Adv Mater       Date:  2012-04-23       Impact factor: 30.849

7.  Engaging adaptive immunity with biomaterials.

Authors:  Carolina Mora-Solano; Joel H Collier
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

Review 8.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

9.  Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis.

Authors:  Berent J Prakken; Rodrigo Samodal; Tho D Le; Francesca Giannoni; Gisella Puga Yung; John Scavulli; Diane Amox; Sarah Roord; Isme de Kleer; Dustan Bonnin; Paola Lanza; Charles Berry; Margherita Massa; Rosario Billetta; Salvatore Albani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

10.  Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.

Authors:  Keli L Hippen; Paul Harker-Murray; Stephen B Porter; Sarah C Merkel; Aryel Londer; Dawn K Taylor; Megan Bina; Angela Panoskaltsis-Mortari; Pablo Rubinstein; Nico Van Rooijen; Tatiana N Golovina; Megan M Suhoski; Jeffrey S Miller; John E Wagner; Carl H June; James L Riley; Bruce R Blazar
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.